Delivery Order SPE2DB22D2214-SPE2DB25FS2JK

Award Date 10/8/24
Potential Completion Date 10/9/24
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,464,842 units of Teriparatide 600 mcg/2.4 ml pen, 2.4 ml. The contract is a firm fixed-price delivery order with a ceiling value of $8,225.76 and an ultimate completion date of May 2, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $5,108.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,568,078,779 units of the medication Teriparatide 560MCG/2.24ML Pen 2.24ML. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,375.14 firm fixed-price delivery order is for the supply of TERIPARATIDE 560MCG/2.24ML PEN 2.24ML, a medication. The contract has an ultimate completion date of June 17, 2025 and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors....
This federal contract award is for the delivery of 4,565,282,725 units of teriparatide 600 mcg/2.4 ml pen, a specialty pharmaceutical medication. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,080.51 and is structured as a delivery order with a firm fixed price. The period of performance runs through July 30, 2024. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,591.28 firm fixed-price delivery order is for the supply of 4,566,328,918 units of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a medication used in the treatment of osteoporosis. The contract has an ultimate completion date of November 5, 2024 and does not utilize any set-aside designation. AmerisourceBergen Drug...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a wholly owned subsidiary of Amerisourcebergen Corporation, to provide 4,563,927,592 units of the pharmaceutical product Teriparatide 600 mcg/2.4ml pen at a ceiling value of $2,299.97. The award, which has an ultimate completion date of March 12, 2024, is part of a larger indefinite delivery contract (IDC) valued up to...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,135.48 firm-fixed-price delivery order is for the supply of teriparatide 600 mcg/2.4 ml pens, a specialty medication. The contract has a ceiling value of $8,135.48 and a completion date of September 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,322.27 firm fixed-price delivery order is for the supply of 560mcg/2.24ml pens of the drug teriparatide, a medication used to treat osteoporosis. The contract has an ultimate completion date of June 18, 2025 and does not have a set-aside designation, indicating open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,289.24, is for the delivery of 4,567,969,223 units of the medication Teriparatide 560MCG/2.24ML Pen 2.24ML. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,701.55, is a Firm Fixed Price Delivery Order for the supply of Teriparatide 620 MCG/2.48 ML 2.48ML, a specialty medication. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS2JK
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $29,830.25 firm fixed-price delivery order is for the supply of 4,566,054,436 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has an ultimate completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 1/7/25, 11:44 AM